Drugs.com - New Drug Approvals

Argenx Announces FDA Approval of Vyvgart Hytrulo Prefilled Syringe for Self-Injection

April 10, 2025 -- argenx SE (Euronext & Nasdaq: ARGX), a global immunology company committed to improving the lives of people suffering from severe autoimmune diseases, today announced that the U.S. Food and Drug Administration (FDA) approved a...

Apr 14, 2025 - 07:40
 0
Argenx Announces FDA Approval of Vyvgart Hytrulo Prefilled Syringe for Self-Injection
April 10, 2025 -- argenx SE (Euronext & Nasdaq: ARGX), a global immunology company committed to improving the lives of people suffering from severe autoimmune diseases, today announced that the U.S. Food and Drug Administration (FDA) approved a...
Read More

Tags:

Previous Article

Discover Airlines to introduce Panasonic Avionics high-speed wifi

Next Article

Tartana's Mungana moves become clearer

Related Posts

FDA Approves Odactra for the Treatment of House Dust Mite Allergy in Young Children

FDA Approves Odactra for the Treatment of House Dust Mi...

Mar 1, 2025  0

Rhythm Pharmaceuticals Announces FDA Approval of Imcivree (setmelanotide) for Patients as Young as 2 Years Old

Rhythm Pharmaceuticals Announces FDA Approval of Imcivr...

Feb 9, 2025  0

Calquence Plus Chemoimmunotherapy Approved in the U.S. for Patients with Previously Untreated Mantle Cell Lymphoma

Calquence Plus Chemoimmunotherapy Approved in the U.S. ...

Feb 9, 2025  0